Euglena Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Employees
  • 1,050

Employees

  • Stock Symbol
  • 2931

Stock Symbol

  • Investments
  • 14

  • Share Price
  • $2.68
  • (As of Friday Closing)

Euglena General Information

Description

euglena Co Ltd is a biotechnology company that researches, develops, produces, and markets microalgae. The company focuses on commercializing its algae research for a variety of uses, including functional foods and cosmetics. Euglena also researches ways to use its microalgae for carbon capture and biofuel production.

Contact Information

Website
www.euglena.jp
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • G-Base Tamachi 2nd Floor
  • 5-29-11 Shiba, Minato-ku
  • Tokyo, 108-0014
  • Japan
+81
Primary Industry
Food Products
Other Industries
Personal Products
Stock Exchange
TKS
Vertical(s)
CleanTech, Life Sciences
Corporate Office
  • G-Base Tamachi 2nd Floor
  • 5-29-11 Shiba, Minato-ku
  • Tokyo, 108-0014
  • Japan
+81

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Euglena Stock Performance

As of 08-Nov-2024, Euglena’s stock price is $2.68. Its current market cap is $365M with 136M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.68 $2.62 $2.59 - $5.39 $365M 136M 844K -$0.11

Euglena Financials Summary

As of 30-Jun-2024, Euglena has a trailing 12-month revenue of $317M.

In Thousands,
USD
TTM 30-Jun-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 30-Sep-2021
EV 515,696 645,253 961,125 994,321
Revenue 317,373 330,809 337,791 216,665
EBITDA 9,422 9,501 9,976 (22,730)
Net Income (13,446) (18,874) (20,332) (22,616)
Total Assets 436,757 422,740 436,814 572,282
Total Debt 167,170 177,771 169,463 230,365
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Euglena Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Euglena‘s full profile, request access.

Request a free trial

Euglena Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
euglena Co Ltd is a biotechnology company that researches, develops, produces, and markets microalgae. The company focus
Food Products
Tokyo, Japan
1,050 As of 2023

Chassieu, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Euglena Competitors (1)

One of Euglena’s competitors is Amoeba, a Formerly VC-backed company based in Chassieu, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amoeba Formerly VC-backed Chassieu, France
You’re viewing 1 of 1 competitors. Get the full list »

Euglena Patents

Euglena Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024143365-A Antiviral agent, antiviral food composition, and antiviral cosmetic composition Pending 30-Mar-2023
JP-2024121434-A Medium composition, yeast growth promoter, regulator of aroma components produced by yeast, method for cultivating yeast, method for changing aroma components produced by yeast, method for changing aroma components of fermented foods, and method for producing fermented foods Pending 27-Feb-2023
JP-2024111715-A Food composition for preventing disorders caused by air pollution and preventive agent for disorders caused by air pollution Pending 06-Feb-2023
JP-2024103208-A Aqueous composition, anti-inflammatory agent, moisturizing agent, food composition for anti-inflammatory or moisturizing purposes, and method for producing the aqueous composition Pending 20-Jan-2023
JP-2024103041-A Method of pest control by foliar spray of ergothioneine Pending 20-Jan-2023
To view Euglena’s complete patent history, request access »

Euglena Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Euglena Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Euglena‘s full profile, request access.

Request a free trial

Euglena Investments & Acquisitions (14)

Euglena’s most recent deal was a Merger/Acquisition with Satis Pharmaceutical. The deal was made on 10-Jan-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Satis Pharmaceutical 10-Jan-2024 Merger/Acquisition Pharmaceuticals
Misaky.Tokyo 21-Nov-2023 Early Stage VC Food Products
Joint Venture (Petronas / Eni / Euglena) 14-Dec-2022 Joint Venture Energy Exploration
Frembassy 01-Feb-2022 Merger/Acquisition Food Products
Q'Sai 01-Feb-2021 Buyout/LBO Food Products
You’re viewing 5 of 14 investments and acquisitions. Get the full list »

Euglena Subsidiaries (1)

Company Name Industry Location Founded
Genequest Laboratory Services (Healthcare) Tokyo, Japan
To view Euglena’s complete subsidiaries history, request access »

Euglena ESG

Risk Overview

Risk Rating

Updated May, 16, 2024

30.75 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,035

Rank

Percentile

Household Products

Industry

of 104

Rank

Percentile

Personal Products

Subindustry

of 81

Rank

Percentile

To view Euglena’s complete esg history, request access »

Euglena Exits (2)

Euglena’s most recent exit was on 15-May-2018 from Medcare. The exit was categorized as with 8 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Medcare 15-May-2018 Completed
  • 8 buyers
Amelieff 31-Jan-2016 Corporate Completed
To view Euglena’s complete exits history, request access »

Euglena FAQs

  • When was Euglena founded?

    Euglena was founded in 2005.

  • Where is Euglena headquartered?

    Euglena is headquartered in Tokyo, Japan.

  • What is the size of Euglena?

    Euglena has 1,050 total employees.

  • What industry is Euglena in?

    Euglena’s primary industry is Food Products.

  • Is Euglena a private or public company?

    Euglena is a Public company.

  • What is Euglena’s stock symbol?

    The ticker symbol for Euglena is 2931.

  • What is the current stock price of Euglena?

    As of 08-Nov-2024 the stock price of Euglena is $2.68.

  • What is the current market cap of Euglena?

    The current market capitalization of Euglena is $365M.

  • What is Euglena’s current revenue?

    The trailing twelve month revenue for Euglena is $317M.

  • Who are Euglena’s competitors?

    Amoeba is a competitor of Euglena.

  • What is Euglena’s annual earnings per share (EPS)?

    Euglena’s EPS for 12 months was -$0.11.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »